Role of in vitro cholesterol depletion in mediating human platelet aggregation

29Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We investigated the direct role of cholesterol lowering on human platelet aggregation by in vitro cholesterol depletion using methyl-β-cyclodextrin. Collagen and thrombin receptor agonist peptide induced maximal aggregation was significantly decreased in cholesterol depleted platelets. In contrast, anti-CD9 antibody, mAb7, or anti-β3 antibody, D3, induced percent maximal aggregation was unaffected by cholesterol depletion. Surface and total αIIbβ3 levels were equivalent in both groups. Morphological and ultrastructural analysis ofcollagen induced aggregates revealed that normal and cholesterol depleted platelets changed shape and aggregated; however, cholesterol depletion impaired microtubule ring formation and aggregate size. Cholesterol depletion also diminished the extent ofthe open canalicular system and collagen induced platelet ATP release. These data suggest cholesterol depletion impairs platelet aggregation by altering platelet ultrastructure critical in mediating secretion. Temporal differences and differences in tyrosine phosphoprotein levels following collagen stimulation were observed, thereby indicating that platelet signaling was concurrently affected by cholesterol depletion. © 2003 International Society on Thrombosis and Haemostasis.

Cite

CITATION STYLE

APA

Grgurevich, S., Krishnan, R., White, M. M., & Jennings, L. K. (2003). Role of in vitro cholesterol depletion in mediating human platelet aggregation. Journal of Thrombosis and Haemostasis, 1(3), 576–586. https://doi.org/10.1046/j.1538-7836.2003.00087.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free